Legal Representation
Attorney
John A. Clifford
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 25, 2006 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Apr 25, 2006 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Sep 27, 2005 | CNSI | S | INQUIRY AS TO SUSPENSION MAILED | Loading... |
| Sep 27, 2005 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Sep 24, 2005 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Mar 14, 2005 | CNSL | S | LETTER OF SUSPENSION MAILED | Loading... |
| Mar 13, 2005 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Mar 11, 2005 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Feb 25, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 25, 2005 | I | PAPER RECEIVED | Loading... | |
| Aug 19, 2004 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Aug 18, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 4, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of radioimmune diseases, namely radloimmunotherapeutics; pharmaceutical preparations in the nature of drug antibody and toxin-antibody conjugates for the purpose of removing and fighting toxins in the body; pharmaceutical preparations in the nature of targeted therapeutics for the diagnosis, therapy and/or prevention of human conditions or disease, namely for use in the treatment of cancer, specifically blood borne cancers and solid tumors; pharmaceutical preparations in the nature of drug delivery agents consisting compounds that facilitate delivery of a wide range of pharmaceuticals comprised of proteins, peptides, peptidomimetics, lipids, carbohydrates, nucleic acids, aptamers, and/or synthetic organic molecules, that selectively bind to any human or bacterial cell, any cell type, any fungus, any virus, any human pathogen, or any component of the above, including fragments and semi-synthetic derivatives
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical drug development services; scientific research in the field of pharmaceuticals; medical and scientific research, namely conducting clinical trials of pharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042